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Résumé en
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BACKGROUND: Mitochondrial DNA (mtDNA) diseases are rare disorders whose
prevalence is estimated around 1 in 5000. Patients are usually tested only for
deletions and for common mutations of mtDNA which account for 5-40% of cases,
depending on the study. However, the prevalence of rare mtDNA mutations is not
known. METHODS: We analysed the whole mtDNA in a cohort of 743 patients
suspected of manifesting a mitochondrial disease, after excluding deletions and
common mutations. Both heteroplasmic and homoplasmic variants were identified
using two complementary strategies (Surveyor and MitoChip). Multiple
correspondence analyses followed by hierarchical ascendant cluster process were
used to explore relationships between clinical spectrum, age at onset and localisation
of mutations. RESULTS: 7.4% of deleterious mutations and 22.4% of novel putative
mutations were identified. Pathogenic heteroplasmic mutations were more frequent
than homoplasmic mutations (4.6% vs 2.8%). Patients carrying deleterious mutations
showed symptoms before 16 years of age in 67% of cases. Early onset disease (<1
year) was significantly associated with mutations in protein coding genes (mainly in
complex I) while late onset disorders (>16 years) were associated with mutations in
tRNA genes. MTND5 and MTND6 genes were identified as 'hotspots' of mutations,
with Leigh syndrome accounting for the large majority of associated phenotypes.
CONCLUSIONS: Rare mitochondrial DNA mutations probably account for more than
7.4% of patients with respiratory chain deficiency. This study shows that a
comprehensive analysis of mtDNA is essential, and should include young children, for
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